Author: user (UserName LastName)

Home user
Post

SCHOOL REOPENINGS NOT SPARKING NEW OUTBREAKS

Researchers announced last week that schoolchildren do not appear to be contributing to new COVID infections, and the majority of available evidence suggests there is only a limited risk of transmission from the young to adults. The New York Times reported data seems encouraging that in-person learning could be safe for young children. Harvard Medical School...

Post

ILLINOIS: RESTAURANT RUINATION RULES

With restaurant and bar owners in Illinois already going broke or busted, and winter coming and outdoor dining not an option, Governor J.B. Pritzker declared the suspension of indoor dining and bar service and strict rules for gatherings in regions throughout the state. TREND FORECAST: The Sun-Times reported that Pritzker’s office has received blowback from businesses...

Post

BOSTON PUBLIC SCHOOLS GO REMOTE-ONLY

Boston public schools announced last week they would switch to remote-only learning due to an increase in COVID-19 cases in the city, reports said. Brenda Cassellius, the superintendent for the city’s schools, told parents in a letter last Wednesday that the city’s positivity rate increased from 4.1 percent earlier this month to 5.7 percent. Roxi...

Post

CASES UP, PCR TEST FAILS

With headline news hysteria selling the new surge of COVID cases and nations again locking down, virtually ignored is the fact that the virus tests are questionable. In our 29 September article, “COVID GOLD TEST PROVES TO BE ‘WORTHLESS,’” we reported on the misleading data from the commonly administered PCR test called the “gold standard”...

Post

SOUTH KOREA: CONNECTION BETWEEN FLU SHOTS AND RECENT DEATHS? 

While the Presstitutes, politicians, and Big Pharma keep promoting, with anxious anticipation, the arrival of a successful vaccine to end the COVID War, barely reported are the approximately 50 South Koreans who died after receiving flu shots, according to Reuters. While the Director of the Korean Disease Control and Prevention Agency (KDCA) said “it is...

Post

COVID VACCINATIONS: “OPERATION WARP SPEED”  

As previously reported in the Trends Journal, nations across the globe have been rushing to get out a COVID-19 vaccine as quickly as possible. The winners of the COVID vaccination sweepstakes are headline news: “Coronavirus vaccine: Short cuts and allegations of dirty tricks.” – BBC, 22 August “Wealthy countries have already pre-ordered more than two...

Post

MEDICAL LAB IN A BAND-AID

A translucent strip the size of a Band-Aid and embedded with electrochemical sensors can detect the presence of various substances and chemical signals in the body by analyzing sweat. The “lab on a strip” was developed by researchers at four Brazilian universities and the country’s Center for Research in Energy and Materials. The strip itself...

Post

REVIVING NUCLEAR POWER

Attempting to bring the nuclear power industry back to life, the U.S. Energy Department’s “Advanced Reactor Demonstration Program” has chosen two novel designs to receive up to $1.6 billion in funding to put them into operation by 2028. Terrapower, a U.S. company, has partnered with GE Hitachi Nuclear Energy to build its “Natrium” reactor, which...

Post

RETURN OF THE DUST BOWL

Dust storms across the U.S. central plains states have become more frequent and intense over the last 20 years, according to a study by multi-disciplinary team of meteorologists and atmospheric scientists. Andy Lambert, a meteorologist at the U.S. Naval Research Laboratory, noticed the trend when he reviewed satellite data about atmospheric dust and haze. He...

BIG PHARMA DRUG DEALER PLEADS GUILTY
Post

BIG PHARMA DRUG DEALER PLEADS GUILTY

Purdue Pharma, the maker of Oxycontin, the highly addictive opioid, pleaded guilty last week in connection to the marketing of the painkiller that experts say contributed to the country’s drug opioid epidemic. The New York Times reported the guilty plea, and the approximately $8.3 billion settlement does not eliminate all litigation against the company, but the...

Skip to content